Inactive Instrument

News Tenzing Acquisition Corp. Nasdaq

Equities

TZACU

VGG8708A1241

Summary

Unlock all the news: Be the first to know and act before the market!

Reviva Pharmaceuticals Holdings, Inc. to Present at the Maxim Group Inaugural 2021 Emerging Growth Virtual Conference	21-03-11	GL
REVIVA PHARMACEUTICALS : Changes in Registrant's Certifying Accountant, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K/A)	21-01-20	AQ
REVIVA PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	21-01-14	AQ
REVIVA PHARMACEUTICALS HOLDINGS, INC. : Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits, Unregistered Sale of Equity Securities, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Amendment or Waiver to Code of Ethics, (form 8-K)	20-12-18	AQ
Tenzing Acquisition Corp.(NasdaqCM:TZAC) dropped from NASDAQ Composite Index	20-12-14	CI
Reviva Pharmaceuticals, Inc. completed the acquisition of Tenzing Acquisition Corp. in a reverse merger transaction.	20-12-13	CI
Tenzing Acquisition Corp. announced that it has received $0.2 million in funding from Tenzing LLC	20-11-11	CI
Tenzing Acquisition Corp. and Reviva Pharmaceuticals, Inc. Announce the Appointment of Narayan Prabhu as Chief Financial Officer	20-11-04	CI
Tenzing Acquisition Corp. Reports Earnings Results for the Second Quarter Ended August 31, 2020	20-10-14	CI
Tenzing Acquisition Corp. announced that it has received $0.35 million in funding from Tenzing LLC	20-09-23	CI
Tenzing Acquisition Corp. announced that it has received $0.125 million in funding from Tenzing LLC	20-08-17	CI
Tenzing Acquisition Corp. announced that it has received $0.175 million in funding from Tenzing LLC	20-07-23	CI
Tenzing Acquisition Corp. : and Reviva Pharmaceuticals, Inc. Announce Execution of Definitive Agreement and Plan of Merger for Business Combination	20-07-21	PR
Reviva Pharmaceuticals, Inc. entered into a definitive agreement to acquire Tenzing Acquisition Corp. for $64 million in a reverse merger transaction.	20-07-20	CI
Tenzing Acquisition Corp. Reports Earnings Results for the First Quarter Ended May 31, 2020	20-07-07	CI
Tenzing Acquisition Corp. : Announces Extension of Deadline to Complete a Business Combination	20-05-21	PR
Tenzing Acquisition Corp. Reports Earnings Results for the Full Year Ended February 29, 2020	20-05-04	CI
Tenzing Acquisition Corp. : Announces Extension of Deadline to Complete a Business Combination	20-02-18	PR
Tenzing Acquisition Corp. announced that it has received $0.75 million in funding from Tenzing LLC	20-02-09	CI
Tenzing Acquisition Corp. Reports Earnings Results for the Third Quarter Ended November 30, 2019	20-01-10	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Tenzing Acquisition Corp. Nasdaq

Equities

TZACU

VGG8708A1241

Summary

Filters